All publications utilizing the gPATH facility should acknowledge support from the UNC - Lineberger Comprehensive Cancer Center University Cancer Research Fund. "The UNC gPATH Facility is supported in part by the Lineberger Comprehensive Cancer Center UCRF"



Grilley-Olson JE, Keith K, Deal AM, Ivanova A, Hayward M, Parker J, Patel N, Eberhard DA, Weck K, Mieczkowski P, Dees EC, Muss H, Reeder-Hayes K, Jolly T, Earp HS, Sharpless N, Carey L, Hayes DN, Anders C. Genomic Sequencing in Metastatic Breast Cancer Patients to Inform Clinical Practice at the University of North Carolina at Chapel Hill. Accepted, SABCS 2015.

Jo, H, Patel, NM, Weck, KE, Eberhard, DA, Hayes, DN, Parker, JS, Hayward, M, Salazar, A, Grilley-Olson, JE. Correlating Molecular and Histopathological Tumor Purity: An Analysis of 816 Patients. Cancer Res. 74:598, October 1, 2014; doi: 10.1158/1538-7445. AM2014-5598

Eberhard, D, Clinical Reporting of NGS data. Eur. J. Cancer 49 (Suppl. 4):S3, 2013

Patel, NM, Eberhard, DA, Trembath, D, Kaiser-Rogers, K, Rao, K, Gulley, M, Funkhouser, W, Thorne, L, Parker, J, Grilley-Olson, J, Sharpless, N, Hayes, DN, Weck, KE. Verification and Reporting of Somatic Mutation Results from Massively Parallel Sequencing in a Clinical Setting: The UNCseq Experience. J. Mol. Diagn. 15:903, 2013

Book Editor:

Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development, Potts, SJ, Eberhard, DA, Wharton Jr, KA, eds Methods in Pharmacology and Toxicology, Springer New York, 2015. ISBN 978-1-4939-2680-0

Book Chapters:

McGinniss MJ, Eberhard DA, Wharton Jr KA. Next Generation Sequencing (NGS) in Anatomic Pathology Discovery and Practice. In: Molecular Histopathology and Tissue Biomarkers in Drug and Diagnostic Development, Potts SJ et al., eds. Methods in Pharmacology and Toxicology, Springer New York, 2015. ISBN 978-1-4939-2680-0, pp 219-257.

Eberhard DA. EGFR Mutations, Other Molecular Alterations Related To Sensitivity to EGFR Inhibitors, and Molecular Testing for EGFR-Targeted Therapies in Non-Small Cell Lung Cancer. In: Haley JD and Gullick WJ, eds. EGFR Signaling Networks in Cancer Therapy, Humana Press, 2008, pp 293-336.

Peer Reviewed Papers:

Montgomery, ND, Parker, JS, Eberhard, DA, Patel, NM, Weck, KE, Sharpless, NE, Hu, Z, Hayes, DN, Gulley, ML. Identification of Human Papillomavirus Infection in Cancer Tissue by Targeted Next Generation Sequencing. In press, Applied Immunohistochem Mol Morphol 2015.

Zhao, X, Wang, A, Patel, N, Eberhard, DA, Walter, VA, Hayward, M, Salazar, AH, Parker, JS, Yin, X, Zhang, G, Siegel, M, Rosson, GB, Earp, HS, Sharpless, NE, Gulley, ML, Weck, KE, Hayes, DN, Moschos, SJ. Targeted Sequencing in Formalin-Fixed Paraffin-Embedded Lung Cancer Specimens using the University of North Carolina Sequencing (UNCseq) Assay. PLoS ONE 2015; 10(6): e0129280. doi:10.1371/journal.pone.0129280.

Jeck WR, Parker J, Carson CC, Shields JM, Sambade MJ, Peters EC, Burd CE, Thomas NE, Chiang DY, Liu W, Eberhard DA, Ollila D, Grilley-Olson J, Moschos S, Neil Hayes D, Sharpless NE. Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma. Pigment Cell Melanoma Res. 2014 Jul;27(4):653-63. doi: 10.1111/pcmr.12238. Epub 2014 Apr 7. PubMed PMID: 24628946; PubMed Central PMCID: PMC4121659.